Replies to post #141513 on Anavex Life Sciences Corp (AVXL)

[sokol]

Link: https://www.centerwatch.com/cwweekly/2018/02/05/gottlieb-outlines-fdas-future-approach-precision-medicine-davos/

[polarbear77]

Wow Sokol, not sure I’d read those particular Dr G remarks from 2/5/18 at Davos.

Difficult to overemphasize his quotes as it relates to our particular situation along with other small biotechs.

Appears that the needs & perspectives of patients suffering from debilitating diseases (of significant unmet need) will be the primary focus, rather than insisting upon the old and outdated/inefficient/massive/long trials chasing the wrong endpoints & targets.

Time will tell if Anavex can benefit from the paradigm shift.

Great post, thank you.

[Investor2014]

This was something I noted with interest when listening to the Davos panel discussion.

We have long term safety and apparent efficacy on several potential endpoints. Seems to me an approval to use A2-73 while thereby studying larger cohorts over time could be a possible outcome.